Overview At Tekton Research’s Moore, OK site, Principal Investigator Dr. Lacy Anderson and team delivered outstanding performance on a complex GLP-1 medication research study, meeting their enrollment goal of 13 participants a full three months early. Despite the operational demands and numerous moving parts typical of obesity trials, the site executed with exceptional coordination, speed, … Read more
Overview At Tekton Research’s Yukon, OK site, Principal Investigator Dr. Robert Lockwood delivered standout performance in a Phase 2 migraine treatment study: meeting enrollment goals early, maintaining 100% patient retention, and achieving one of the sponsor’s highest eDiary compliance rates across all participating sites. His team’s performance not only exceeded expectations but also earned the … Read more
Objective Tekton’s Wichita, KS site with lead PI Dr. Brandon Alleman was selected to support a recent clinical trial evaluating a continuous glucose monitoring (CGM) device in pregnant women with diabetes. Pregnancy introduces unique challenges in managing glucose levels, making CGM a vital tool for optimizing maternal and fetal health. Challenge The study presented unique … Read more
Overview Tekton Research played a pivotal role in advancing a recent Alzheimer’s Disease clinical trial, demonstrating exceptional performance across enrollment, site readiness, and strategic consultation. Our team not only enrolled the study’s first patient but also exceeded initial recruitment expectations, delivering high-quality data while supporting a newly engaged Principal Investigator (PI) through our robust training … Read more
Objective Tekton was selected to deliver research sites and participants for a Global Phase 3 vaccine clinical trial. The study required a population of generally healthy adults and demanded rapid site activation and participant enrollment to meet aggressive study timelines. Challenge Norovirus, a highly contagious virus causing gastrointestinal illness, presents significant global public health challenges. … Read more
Marlboro, NJ – Tekton Research is pleased to announce that Amor R. Mehta, MD, a leading neurologist specializing in epilepsy, seizure disorders and neurodegenerative diseases, has joined the organization’s collaborative network. With a strong commitment to advancing epilepsy care and epilepsy-related neurodiagnostics in New Jersey, Dr. Mehta brings an unparalleled dedication to enhancing patient outcomes … Read more
Longmont, CO – Tekton Research, a prominent leader in clinical trials with a nationwide network of research facilities established in 2006, is excited to announce its recent partnership with Dr. Alex Reish. An esteemed osteopath specializing in migraines and chronic pain, Dr. Reish joins Tekton Research with a strong passion for innovative care and extensive … Read more
As flu season approaches, Tekton Research is conducting vital studies to enhance vaccine development and is seeking volunteers aged 50 and older to participate. These trials are essential for developing improved protections against the flu, which claims thousands of lives each year. Why This Research Matters “Flu kills thousands of people of all ages every … Read more
YUKON, OKLAHOMA —For more than a decade now, Tekton Research has never wavered from its focus of operating successful clinical trials across a network of clinical research locations throughout the United States. Tekton continues to grow, partnering with experienced research physicians, to pursue an investigative passion to uncover new information that may lead to discovering … Read more
Austin, TX – Tekton Research, a clinical research company focusing on clinical trials for pharmaceuticals and device companies, is excited to announce the appointment of Jeffrey Zucker as Vice President of Neurology Operations. In this role, Jeffrey will oversee commercial strategy, client outreach, site expansion, and other critical functions supporting all Neurology site locations. Jeffrey … Read more